Good morning, everyone, and how are you today? We are just fine, thank you, despite the rather gloomy skies hovering over the Pharmalot campus. After all, why allow a few puffy clouds to deter you? Moreover, we are keeping our spirits up by quaffing a few cups of stimulation (not those other types of spirits). We have returned to Cinnamon Dolce, in fact, for those keeping track. Meanwhile, here are some tidbits. Hope you have a delightful day …
Abbas Hussain, the global head of pharmaceuticals at GlaxoSmithKline, is leaving after being passed over for the top job. He will be replaced by Luke Miels, currently executive vice president of the AstraZeneca European business. Hussain, who joined Glaxo in 2008, was in the running to succeed Andrew Witty as Glaxo CEO, but the job went to Emma Walmsley, who has been in charge of the Glaxo consumer healthcare business, Reuters notes.
About the Author Reprints
